Ky Nguyen
Family Medicine · Westminster, CANPI 1972782829
Payments from drug & device makers
Across 165 payments — averaging $88.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AstraZeneca$2K
- Boehringer Ingelheim$2K
- Gilead$870
- Lilly USA, LLC$863
- Phathom Pharmaceuticals, Inc.$463
- plus $4K from 21 others
What the payments were for
- Travel & lodging$60%
- Food & beverage$14,604100%
- Education$340%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 60 | $4,414 |
| AstraZeneca | 19 | $2,208 |
| Boehringer Ingelheim | 22 | $2,060 |
| Gilead | 7 | $870 |
| Lilly USA, LLC | 9 | $863 |
| Phathom Pharmaceuticals, Inc. | 4 | $463 |
| Johnson & Johnson | 5 | $457 |
| Amarin Pharma, Inc. | 7 | $404 |
| Novo Nordisk | 9 | $395 |
| Inari Medical, Inc. | 2 | $270 |
| Mayne Pharma Commercial LLC | 2 | $246 |
| Intercept Pharmaceuticals, Inc. | 2 | $234 |
| Redhill Biopharma Inc. | 1 | $144 |
| Abbott | 1 | $134 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Ardelyx, Inc. | 1 | $125 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| AbbVie | 1 | $125 |
| Novartis | 1 | $122 |
| Idorsia Pharmaceuticals US Inc | 1 | $120 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $120 |
| Bard Peripheral Vascular, Inc. | 1 | $119 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $110 |
| Radius Health, Inc. | 1 | $107 |
| Merck | 1 | $106 |
| Genentech USA, Inc. | 3 | $53 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,643 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 70 | $65,438 |
| Repatha SureclickEvolocumab | 40 | $23,434 |
| LinzessLinaclotide | 33 | $21,230 |
| JanuviaSitagliptin Phosphate | 19 | $18,019 |
| RestasisCyclosporine | 21 | $13,215 |
| OzempicSemaglutide | 15 | $12,637 |
| RybelsusSemaglutide | 11 | $9,243 |
| VascepaIcosapent Ethyl | 14 | $5,488 |
| Rosuvastatin Calcium | 58 | $1,017 |
| Losartan Potassium | 79 | $1,015 |
| Atorvastatin Calcium | 85 | $937 |
| Amlodipine Besylate | 132 | $510 |
| Metformin Hcl | 50 | $468 |
| Valsartan | 11 | $428 |
| Alendronate Sodium | 75 | $384 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $2,060 | $65,43870 claims |
| AbbVieLinzess, Restasis | $125 | $34,44554 claims |
| Novo NordiskOzempic, Rybelsus | $395 | $21,88126 claims |
| MerckJanuvia | $106 | $18,01919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,533 family medicine providers in California.
Other family medicine in Westminster
- Dinh DinhWestminster$993K
- Amina HaggagNorthridge$112.8M
- Steven ReynoldsLong Beach$53M
- Rizwana MohseniLake Forest$26.7M
- Daniel JohnsonSan Diego$15.7M
- Stacey LayleSan Diego$14.8M
- Apinya VutikullirdCypress$14.3M
- Hanid AudishSpring Valley$13.6M
- Augusto FocilOxnard$12.6M
- Jack VuLong Beach$10.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.